skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 22,776  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Anti-obesity drug discovery: advances and challenges
Material Type:
Article
Add to My Research

Anti-obesity drug discovery: advances and challenges

Nature reviews. Drug discovery, 2022-03, Vol.21 (3), p.201-223 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00337-8 ;PMID: 34815532

Full text available

2
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

The New England journal of medicine, 2016-11, Vol.375 (18), p.1799 [Peer Reviewed Journal]

EISSN: 1533-4406 ;PMID: 27806237

Full text available

3
Type 2 diabetes
Material Type:
Article
Add to My Research

Type 2 diabetes

The Lancet (British edition), 2022-11, Vol.400 (10365), p.1803-1820 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01655-5 ;PMID: 36332637

Full text available

4
Advances in oral peptide therapeutics
Material Type:
Article
Add to My Research

Advances in oral peptide therapeutics

Nature reviews. Drug discovery, 2020-04, Vol.19 (4), p.277-289 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2019. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-019-0053-0 ;PMID: 31848464

Full text available

5
Cellular and Molecular Mechanisms of Metformin Action
Material Type:
Article
Add to My Research

Cellular and Molecular Mechanisms of Metformin Action

Endocrine reviews, 2021-02, Vol.42 (1), p.77-96 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. 2020 ;Copyright © Oxford University Press 2015 ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 0163-769X ;EISSN: 1945-7189 ;DOI: 10.1210/endrev/bnaa023 ;PMID: 32897388

Full text available

6
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Material Type:
Article
Add to My Research

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European heart journal, 2022-02, Vol.43 (6), p.474-484 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab777 ;PMID: 35023547

Full text available

7
Forget polypharmacy for type 2 diabetes! Weight management is a better investment
Material Type:
Article
Add to My Research

Forget polypharmacy for type 2 diabetes! Weight management is a better investment

Nephrology, dialysis, transplantation, 2022-04, Vol.37 (5), p.844-846 [Peer Reviewed Journal]

ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfaa250 ;PMID: 33263751

Full text available

8
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial
Material Type:
Article
Add to My Research

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial

Circulation (New York, N.Y.), 2020-04, Vol.141 (15), p.1227-1234 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.044183 ;PMID: 31983236

Full text available

9
Cardiovascular disease in diabetes, beyond glucose
Material Type:
Article
Add to My Research

Cardiovascular disease in diabetes, beyond glucose

Cell metabolism, 2021-08, Vol.33 (8), p.1519-1545 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2021.07.001 ;PMID: 34289375

Full text available

10
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Material Type:
Article
Add to My Research

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Diabetes care, 2020-12, Vol.43 (12), p.2999-3006 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Dec 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-1521 ;PMID: 32994187

Full text available

11
The mechanisms of action of metformin
Material Type:
Article
Add to My Research

The mechanisms of action of metformin

Diabetologia, 2017-09, Vol.60 (9), p.1577-1585 [Peer Reviewed Journal]

The Author(s) 2017 ;Diabetologia is a copyright of Springer, 2017. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-017-4342-z ;PMID: 28776086

Full text available

12
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

The New England journal of medicine, 2016-03, Vol.374 (11), p.1092-1094 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1600827 ;PMID: 26981940

Full text available

13
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Material Type:
Article
Add to My Research

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetologia, 2022-12, Vol.65 (12), p.1925-1966 [Peer Reviewed Journal]

American Diabetes Association and the European Association for the Study of Diabetes 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2022. American Diabetes Association and the European Association for the Study of Diabetes. ;American Diabetes Association and the European Association for the Study of Diabetes 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-022-05787-2 ;PMID: 36151309

Full text available

14
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Material Type:
Article
Add to My Research

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022-03, Vol.28 (3), p.568-574 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-021-01659-1 ;PMID: 35228754

Full text available

15
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
Material Type:
Article
Add to My Research

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia

European heart journal, 2020-10, Vol.41 (40), p.3936-3945 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa689 ;PMID: 32860031

Full text available

16
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

The New England journal of medicine, 2022-09, Vol.387 (12), p.1089-1098 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206286 ;PMID: 36027570

Full text available

17
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Material Type:
Article
Add to My Research

SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

The Lancet (British edition), 2022-09, Vol.400 (10354), p.757-767 [Peer Reviewed Journal]

Copyright © 2022 Published by Elsevier Ltd. All rights reserved. Published by Elsevier Ltd.. All rights reserved. ;2022. Published by Elsevier Ltd. All rights reserved ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01429-5 ;PMID: 36041474

Full text available

18
Empagliflozin in Patients with Chronic Kidney Disease
Material Type:
Article
Add to My Research

Empagliflozin in Patients with Chronic Kidney Disease

The New England journal of medicine, 2023-01, Vol.388 (2), p.117-127 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2204233 ;PMID: 36331190

Full text available

19
Dapagliflozin in Patients with Chronic Kidney Disease
Material Type:
Article
Add to My Research

Dapagliflozin in Patients with Chronic Kidney Disease

The New England journal of medicine, 2020-10, Vol.383 (15), p.1436-1446 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2024816 ;PMID: 32970396

Full text available

20
The health effects of vitamin D supplementation: evidence from human studies
Material Type:
Article
Add to My Research

The health effects of vitamin D supplementation: evidence from human studies

Nature reviews. Endocrinology, 2022-02, Vol.18 (2), p.96-110 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-021-00593-z ;PMID: 34815552

Full text available

Results 1 - 20 of 22,776  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (20,789)

Refine My Results

Creation Date 

From To
  1. Before 1986  (132)
  2. 1986 To 1994  (711)
  3. 1995 To 2003  (2,362)
  4. 2004 To 2013  (8,468)
  5. After 2013  (11,105)
  6. More options open sub menu

Language 

  1. English  (22,078)
  2. Japanese  (2,569)
  3. French  (296)
  4. Spanish  (147)
  5. Portuguese  (107)
  6. German  (90)
  7. Swedish  (74)
  8. Russian  (62)
  9. Norwegian  (47)
  10. Polish  (27)
  11. Chinese  (21)
  12. Italian  (11)
  13. Croatian  (7)
  14. Ukrainian  (4)
  15. Serbian  (2)
  16. Korean  (2)
  17. Lithuanian  (1)
  18. Bosnian  (1)
  19. Dutch  (1)
  20. More options open sub menu

Searching Remote Databases, Please Wait